Join CBSET's partner, CILcare, at BIO-Europe, October 24-26, in Leipzig, Germany.
BIO-Europe attracts a wide range of business leaders, such as: senior executives of leading biotech companies, business development teams from large and midsize pharmaceutical companies, investors, and other industry experts.
Learn more about the work CBSET and CILcare are doing on hearing loss and ototoxicity.
Related CBSET & CILcare Publications:
GLP Preclinical Services for Auditory Safety
Intracochlear Drug Delivery Systems: A Novel Approach Whose Time Has Come. Peppi M, Marie A, Belline C, Borenstein JT. Expert Opinion in Drug Delivery. 2018 Feb 26. doi: 10.1080/17425247.2018.1444026.
World Pharma Today: Auditory Therapy, Ototoxicity, and GLP Compliance: Will the promising market for ear disorder treatments follow ophthalmology’s dramatic growth curve?
by Michael Naimark, Director of Business Development, CBSET, Inc. and Marie-Pierre Pasdelou, PharmD, founder and the Chief Development Officer, CILcare
World Pharma Today: Stem Cell and Regenerative Therapies for Hearing Loss
by Michael Naimark, Director of Business Development, CBSET, Inc. and Marie-Pierre Pasdelou, PharmD, founder and the Chief Development Officer, CILcare